TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Reactivation level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EC50 of the optimized molecules
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour dynamic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: One-Repetition Maximum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Countermovement Jump Height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Catecholamine Response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: oral feeding at ICU discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hidradenitis Suppurativa Clinical Response (HiSCR) 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait Speed test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 400 m Walking Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: InBody muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Surgical outcomes of fallopian tube surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Post-discharge readmission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Oxidative effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LVMI effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Local and systemic solicited AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Number of unsolicited AEs, and SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Magnitude of serum neutralizing activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: GOSE score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perfusion index trend
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline in ADAS-cog score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change from Baseline in CIBIC+ score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: hours of SSC per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental Stress Scale (PSS) NICU
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Foot plantar pressure changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: [18F]FDG uptake in the sgACC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in averaged 24-hour systolic and diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of Participants with POAF
Endpoint domain: Adverse events/effects
Primary endpoint: Pain perception during LA injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shoulder subluxation grade (qualitative method)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Shoulder subluxation grade (quantitative method)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from baseline seizure frequency at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from baseline seizure type at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Complication reporting
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in autistic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness on actinic lentigo
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Effectiveness on actinic keratosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Change in Tandem test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Dizziness disability inventory (BEE) score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Beck anxiety scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to diagnosis of cardiac arrest
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to initiation of cardiopulmonary resuscitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Longest chest compression pause duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proportion of participants completing colorectal cancer screening
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Total/moderate tumor regression rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Remission rate of hyperthyroidism
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Bone gain change radiologically
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Histomorphometric bone changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Number of nights achieving fasting time of 14 h
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VO2max during cardiopulmonary exercise test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Laryngopharyngeal Measure of Perceived Sensation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Glasgow Edinburg Throat Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Progression Free Survival at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Changes in protein expression of inflammatory genes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in gene expression related to fibrosis and inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in expression and location of senescence markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-years Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: 5-years Progression Free Survival
Endpoint domain: Mortality/survival
Primary endpoint: Psychomotor Vigilance Test Reaction Time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: American Shoulder and Elbow Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analogue Scale of Improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in Submental Fat Rating Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the Raman analyzer in detecting gliomar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Specificity of the Raman analyzer in detecting gliomar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Horizontal distance between intergluteal cleft and neuraxial midline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in volume of hyperintense lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Classification performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tegner activity level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Return to pre injury level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Pain severity secondary to dysmenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anxiety level in students with dysmenorrhea
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Symptom severities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in levels of caregiver-reported emotional problems in adolescents
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in levels of social support in adolescents
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in levels of family functioning in caregivers
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Composite Referral Completion Index
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Time to first passage of faeces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Occurrence of clinical events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of depression symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of risk of suicide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change of somatization symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinf of Omeprazole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCinfCR of Caffeine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUClastCR of Efavirenz
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in procedural pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in procedural anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of hand bacterial growth
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: CNS progression-free survival (CNS-PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Cognitive-deterioration-free survival (CD-free survival)
Endpoint domain: Mortality/survival
Primary endpoint: Sustained unresponsiveness to sesame protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Highest tolerated dose of sesame protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of baseline maximum inspiratory pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change of baseline maximum expiratory pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change from baseline ABILHAND
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Changes in parenting skills
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in parenting competencies
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Changes in child emotional and behavioral problems
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Opioid requirement post-operatively
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: PE entrance examination performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perceived usability of the Praxis system
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Isokinetic dynamometer average power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic dynamometer acceleration time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isokinetic dynamometer deceleration time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight change compared to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in tolerability from procedure day to 12 months
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Skin pattern
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Number of Participants who experience a Dose-Limiting Toxicity (DLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Composite of major adverse events (MAE) and complications
Endpoint domain: Adverse events/effects
Primary endpoint: Success or failure at 12 months of being free of atrial arrhythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in symptoms following convergent ablation
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Completeness of caecal intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length-tension properties of the anal sphincter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Front-rear pressure difference (in cmH2O)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Local tumor progression free survival at 24 months
Endpoint domain: Mortality/survival
Primary endpoint: Bronchoscopic score for prediction of tracheobronchial HSV-1 reactivation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myocardial Infarction (MI)
Endpoint domain: Adverse events/effects
Primary endpoint: Cerebral Vascular Event (CVA)
Endpoint domain: Adverse events/effects
Primary endpoint: Acute Renal Failure (ARF)
Endpoint domain: Adverse events/effects
Primary endpoint: Sepsis or septic shock
Endpoint domain: Adverse events/effects
Primary endpoint: Nutritional risk assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with fatigue and hypogammaglobulinemia
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Number of patients with fatigue without hypogammaglobulinemia
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change over time in Catastrophizing
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change over time in (Dis)ability/ pain screening
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change over time in Work ability
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change over time in Functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Mediterranean Lifestyle Index
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reliability of Upper Extremity Rotation Test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any grade 3 or 4 adverse events leading to therapy discontinuation
Endpoint domain: Adverse events/effects
Primary endpoint: width of keratinized gingiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: horizontal width of gingiva
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: horizontal bone resorption of alveolar crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: vertical bone resorption of alveolar crest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: average gray value of alveolar bone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration and time of robot communication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of conversations exchanged
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of participants' vocalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants with preterm birth
Endpoint domain: Mortality/survival
Primary endpoint: resting-state EEG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Success rate of endobronchial intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Pelvic fracture displacement at 5 kg of stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pelvic fracture displacement at 10 kg of stress
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: cost-effectiveness of stapes surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Enrollment rate in clinical research
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Retention rate in clinical research
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of patients achieving and maintaining alcohol abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in cortical silent period (cSP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Rate of renal recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: safety and efficacy of the LUM Imaging System
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Change of TNF α / IL-10 ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Expression of Epithelium-Mesenchymal Markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Profile From Time 0 Extrapolated to Infinity (AUCinf) of Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-time Profile From Time 0 to the Time of the Last Quantifiable Concentration (Clast) (AUClast) of Midazolam
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pregnancy test result
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Lacrimal river height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear-film lipid layer thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Foot And Ankle Ability Measure (FAAM)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Conners Adult ADHD Rating Scale
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adult Concentration Inventory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Depression Anxiety Stress Scale-21
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Trier Social Stress Test
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mind Excessively Wandering Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Change in Global Health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Ehlers-Danlos Syndrome Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of correct diagnosed VRL and vitritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of patients with VRL or vitritis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sleep Diary - Change in total sleep time (TST)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: baseline values of facial mimicry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: baseline values of eye-tracking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum range of motion of facial mimicry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum range of motion of eye-tracking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve of the receiver operation characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of autoimmune adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Assessment of new malignancies
Endpoint domain: Adverse events/effects
Primary endpoint: Intervention credibility and expectancy of benefit
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Trial Completion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Acceptability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Incidence of mechanical and infective phlebitis
Endpoint domain: Adverse events/effects
Primary endpoint: Change in Appearance of the Bladder Mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Frequency of HDV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Efficacy of sabizabulin in treating metastatic breast cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of SpO2 Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of Heart Rate Measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of post operative delirium
Endpoint domain: Adverse events/effects
Primary endpoint: Endogenous antioxidant enzyme 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transcutaneous Carbon Dioxide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes